Nationally ranked healthcare accelerator Health Wildcatters has named 11 startups to its newest class, marking what the Dallas-based program called another milestone in the region’s rise as a health innovation hub.
Now in its 13th year, the accelerator has backed 131 companies to date, reinforcing its role as one of the most active early-stage healthcare investors in the U.S.
“The breadth of this year’s class speaks to the future of healthcare: more digital, more global, and more personalized,” Dr. Hubert Zajicek, CEO and co-founder of Health Wildcatters, said in a statement. “We’re excited to bring this level of innovation into Dallas, where entrepreneurs, investors, and industry leaders come together to accelerate breakthroughs that can truly change lives.”
Dr. Hubert Zajicek, CEO and co-founder of Health Wildcatters [Photo: HealthWildcatters]
Based at Pegasus Park in Dallas, the accelerator recently launched the HW VC Center, a new initiative designed to connect investors and startups.
In the six weeks since it opened, the VC Center has hosted more than 30 meetings with 10 venture capital firms across the country, the accelerator said, fueling deal flow between health innovation startups and investors. That includes members of this year’s cohort, the group added.
Members of the 2025 accelerator
Health Wildcatters said the 2025 class reflects the increasing globalization of healthcare innovation. The cohort includes startups from across the U.S. and abroad—four international companies are represented—offering a mix of health IT, medical devices, digital health, and biopharma solutions.
Here’s a look at the 2025 Health Wildcatters cohort:
● PrecisionHealth TPA (Frisco) — Led by Craig Herndon, the company is reinventing self-funded healthcare with technology-driven operations, transparent pricing, and scalable recurring revenue.
● YU.SH (Milan, Italy | Dubai, UAE) — Founded by Pietro Allegretti, YU.SH merges fashion and health tech with luxury heels equipped with smart insoles that boost wellness through electrostimulation.
● Vaccinity Inc. (Fort Worth) — Founded by Paul Evans, Vaccinity is building a decentralized patient EHR with AI-powered clinical trial matching to expand access and equity.
● Latica Med Ltd. (Ra’anana, Israel) — Eduard Papirov is pioneering non-invasive acoustic technology designed to improve fertility outcomes by enhancing endometrial receptivity and healing.
● Pumpinheart Limited (Galway, Ireland) — Founded by Donald Hickey, Pumpinheart is developing a transcatheter implantable pump for advanced heart failure with preserved ejection fraction (HFpEF), addressing an unmet need affecting millions.
● NearWave (Austin) — Founded by Roy Stillwell, NearWave has created optical imaging systems that help physicians non-invasively identify the best therapy for breast cancer patients within a week.
● Pollen Sense (Salt Lake City, Utah) —Pollen Sense, co-founded by Kris Klein and David Noel, delivers real-time, high-resolution airborne particle insights through a deep-tech platform with transformative applications across health, research, and industry.
● SelfSense Technologies (Galway, Ireland) — Founded by David Townley, SelfSense has developed an AI-powered SmartSplint that monitors bite force in real time to prevent dental implant failures and optimize treatment outcomes.
● HarmonIQ Biosciences Inc. (Austin) — Founded by Mario Sierra, HarmonIQ is pioneering the world’s first continuous hormone monitoring (CHM) platform—“the Dexcom of hormones”—to deliver real-time hormone data and AI-driven insights that transform fertility care, menopause management, testosterone optimization, and endocrine research.
● Sequest Bio (Boston, Massachusetts) — Sequest Bio, founded by Ashkan Novin, leverages biopsies, RNA-sequencing, and live metastasis assays to generate predictive models that provide oncologists with earlier, more accurate insights into how cancer will progress.
● PowerPercept (Dallas) — Led by Avinash Srinivasan, PowerPercept is a health technology company developing smart insoles that provide real-time insights to help prevent injuries and accelerate rehabilitation.
The new startups made their debut at Health Wildcatters’ annual “Meet the Teams Reveal & Happy Hour” on Sept. 4, at Pegasus Park.
HW Team Reveal Gallery
Photos via HealthWildcatters.
Don’t miss what’s next. Subscribe to Dallas Innovates.
Track Dallas-Fort Worth’s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.
R E A D N E X T
-
Combining cutting-edge research and real-world applications, the UT Dallas professor transforms public health with innovations in detection technology, including “a check engine light” for the human body. In collaboration with EnLiSense, the company she cofounded, Dr. Prasad combines chemistry with software and hardware to bring the technology to life as market-ready devices.
-
Moderated by Highlander Health Co-Founder Brad Hirsch, next Wednesday’s free public event will feature two former FDA commissioners and a former FDA acting chief information officer. The focus: “how the FDA has evolved across four presidential administrations.”
-
Focused on community health, this weekend’s April 4-5 hackathon attracted more than 200 applicants, with 120 participants selected to form cross-functional teams of students, researchers, clinicians, engineers, and entrepreneurs.
-
The expansion is aimed at advancing the health innovation incubator’s mission of supporting transformative healthcare startups and connecting them with the resources needed for success. Since 2013, 118 healthcare-focused companies have collectively secured over $350 million in follow-up funding after participating in its accelerator, Health Wildcatters said.
-
Founded in 2012, Universal DX is focused on “cracking cancer’s code” via its multi-omics and machine learning models. Starting with colorectal cancer, it’s building a “multi-cancer platform” that can ID the unique DNA regions associated with different types of cancers.